Nasdaq Eigr News Today

Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) and XOMA (NASDAQ:XOMAP – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Insider and Institutional Ownership 62.5% of Eiger BioPharmaceuticals shares […]

Investment analysts at StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Price Performance Eiger BioPharmaceuticals has a 52-week low of $1.10 and a 52-week high of $43.35. The stock has […]

StockNews.com initiated coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report released on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Performance Shares of EIGR stock opened at $1.30 on Friday. The firm’s 50 day moving average price is $5.72 and its […]

StockNews.com initiated coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note issued to investors on Monday. The firm issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Down 0.3 % EIGR stock opened at $5.80 on Monday. The firm has a 50 day moving average of $6.89 […]

StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a report published on Saturday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Stock Performance Shares of EIGR stock opened at $6.11 on Friday. The company has a debt-to-equity ratio of 2.64, a quick ratio of […]

Shares of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR – Free Report) are going to reverse split before the market opens on Monday, January 8th. The 1-30 reverse split was announced on Monday, January 8th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 8th. Eiger BioPharmaceuticals Trading Down 5.2 […]

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR – Get Free Report) saw a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 1,070,000 shares, a drop of 7.0% from the November 30th total of 1,150,000 shares. Based on an average daily trading volume, of 301,300 shares, the short-interest […]

StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report report published on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Citigroup lowered their target price on shares of Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating for the company […]

StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup lowered their price target on shares of Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating on the […]

StockNews.com assumed coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note issued to investors on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup cut their target price on Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating for the company in […]